Central inhibitory effects on feeding induced by the adipo-myokine irisin

Eur J Pharmacol. 2016 Nov 15:791:389-394. doi: 10.1016/j.ejphar.2016.09.011. Epub 2016 Sep 8.

Abstract

Irisin, the soluble secreted form of fibronectin type III domain containing 5 (FNDC5)-cleaved product, is a recently identified adipo-myokine that has been indicated as a possible link between physical exercise and energetic homeostasis. The co-localization of irisin with neuropeptide Y in hypothalamic sections of paraventricular nucleus, which receives NPY/AgRP projections from the arcuate nucleus, suggests a possible role of irisin in the central regulation of energy balance. In this context, in the present work we studied the effects of intra-hypothalamic irisin (1μl, 50-200nmol/l) administration on feeding and orexigenic [agouti-related peptide (AgRP), neuropeptide Y (NPY) and orexin-A] and anorexigenic [cocaine and amphetamine-regulated transcript (CART) and proopiomelanocortin (POMC)] peptides in male Sprague-Dawley rats. Furthermore, we evaluated the effects of irisin on hypothalamic dopamine (DA), norepinephrine (NE) and serotonin (5-hydroxytryptamine, 5-HT) concentrations and plasma NE levels. Compared to vehicle, irisin injected rats showed decreased food intake, possibly mediated by stimulated CART and POMC and inhibited DA, NE and orexin-A, in the hypothalamus. We also found increased plasma NE levels, supporting a role for sympathetic nervous system stimulation in mediating increased oxygen consumption by irisin.

Keywords: CART; DA; Irisin; NE; Orexin-A; POMC.

MeSH terms

  • Animals
  • Dopamine / blood
  • Eating / drug effects
  • Feeding Behavior / drug effects*
  • Fibronectins / pharmacology*
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • Male
  • Neuropeptides / metabolism
  • Norepinephrine / blood
  • Rats
  • Rats, Sprague-Dawley
  • Serotonin / blood

Substances

  • FNDC5 protein, human
  • Fibronectins
  • Neuropeptides
  • Serotonin
  • Dopamine
  • Norepinephrine